Deadline for applications 15 February 2015 17:00 CET. Download PDF-version
EVI has an exciting career opportunity for junior and motivated individual to join the organisation in an eighteen month full time position as Vaccine Management Assistant (VMA) for a phase I vaccine clinical trial.
Epidemiological evaluation of vaccines: efficacy, safety and policy
The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy.
Almac Group, the contract development and manufacturing organization, today announced its key role in preparing and delivering one of the longest synthetically produced protein fragment to be used as a vaccine in a phase I clinical trial for malaria.
Malaria vaccine tested at RCSI proves successful in first human trial. Two new malaria vaccines which have undergone a clinical trial in humans, carried out by researchers at RCSI in Dublin, have been proven to be well tolerated and produce a strong immune response. An article has been published in Plos one.
For full press release please click here
Ninety people registered for the workshop, which was held at Louise Centre, Avenue Louise 287, Brussels
EVI valued your participation and extends heartfelt thanks for your contribution. We are sure you join EVI in looking forward to witnessing the benefits of the workshop throughout the scientific community.
A report will be available at a later date, alternatively an article is being considered
- 1 of 16